Oscotec Incorporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oscotec Incorporation with three other
companies in this sector in South Korea:
Optipharm Co Ltd
sales of 13.96 billion Korean Won [US$11.66 million]
of which 47%
was Livestock Medicine),
Chem Tech Research Inc
(20.54 billion Korean Won [US$17.15 million]
of which 26%
was OTC entrusted), and
iNtRON Biotechnology Inc
(20.58 billion Korean Won [US$17.19 million]
of which 55%
was Technology Export).
Sales increased substantially in 2018:
During the year ended December of 2018, sales at
Oscotec Incorporation were 18.70 billion Korean Won (US$15.62 million).
increase of 378.5%
versus 2017, when the company's sales were 3.91 billion Korean Won.
Sales of Other Segment saw an increase
379.1% in 2018, from
3.06 billion Korean Won to 14.66 billion Korean Won.